p-gp inhibitors Search Results


p-gp inhibitor zosuquidar  (Biomol GmbH)
90
Biomol GmbH p-gp inhibitor zosuquidar
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
P Gp Inhibitor Zosuquidar, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pmc11374953-253-21-24?v=Biomol+GmbH
Average 90 stars, based on 1 article reviews
p-gp inhibitor zosuquidar - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
arginine-threonine-arginine (rtr), a prolyl-glycyl-proline (pgp)–containing peptides inhibitor  (AnaSpec)
90
AnaSpec arginine-threonine-arginine (rtr), a prolyl-glycyl-proline (pgp)–containing peptides inhibitor
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
Arginine Threonine Arginine (Rtr), A Prolyl Glycyl Proline (Pgp)–Containing Peptides Inhibitor, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pmc03587327-31-14-18?v=AnaSpec
Average 90 stars, based on 1 article reviews
arginine-threonine-arginine (rtr), a prolyl-glycyl-proline (pgp)–containing peptides inhibitor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
potential inhibitors of p-gp  (MolPort Inc)
90
MolPort Inc potential inhibitors of p-gp
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
Potential Inhibitors Of P Gp, supplied by MolPort Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pmc04244591-106-3-16?v=MolPort+Inc
Average 90 stars, based on 1 article reviews
potential inhibitors of p-gp - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
pgp inhibitors val  (TheWell Bioscience Inc)
90
TheWell Bioscience Inc pgp inhibitors val
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
Pgp Inhibitors Val, supplied by TheWell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/10__1074_slash_jbc__m113__514091-90-21-20?v=TheWell+Bioscience+Inc
Average 90 stars, based on 1 article reviews
pgp inhibitors val - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gf120918 (elacridar, p gp inhibitor)  (Merck KGaA)
90
Merck KGaA gf120918 (elacridar, p gp inhibitor)
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
Gf120918 (Elacridar, P Gp Inhibitor), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pmc09320886-75-21-29?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
gf120918 (elacridar, p gp inhibitor) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
p-gp inhibitor vinblastine  (SPI Bio Inc)
90
SPI Bio Inc p-gp inhibitor vinblastine
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
P Gp Inhibitor Vinblastine, supplied by SPI Bio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pm21821074-101-0-5?v=SPI+Bio+Inc
Average 90 stars, based on 1 article reviews
p-gp inhibitor vinblastine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
p-gp inhibitor valspodar  (CEM Corporation)
90
CEM Corporation p-gp inhibitor valspodar
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
P Gp Inhibitor Valspodar, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pmc04375488-51-10-28?v=CEM+Corporation
Average 90 stars, based on 1 article reviews
p-gp inhibitor valspodar - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
p-gp inhibitors  (MolPort Inc)
90
MolPort Inc p-gp inhibitors
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
P Gp Inhibitors, supplied by MolPort Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pmc04618641-64-0-14?v=MolPort+Inc
Average 90 stars, based on 1 article reviews
p-gp inhibitors - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
inhibitors of pgp  (Kemper GmbH)
90
Kemper GmbH inhibitors of pgp
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
Inhibitors Of Pgp, supplied by Kemper GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pm15716304-203-2-24?v=Kemper+GmbH
Average 90 stars, based on 1 article reviews
inhibitors of pgp - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
pgp inhibitor verapamil  (Bioresponse LLC)
90
Bioresponse LLC pgp inhibitor verapamil
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
Pgp Inhibitor Verapamil, supplied by Bioresponse LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pm12357346-102-26-86?v=Bioresponse+LLC
Average 90 stars, based on 1 article reviews
pgp inhibitor verapamil - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
docking routine-identified variants of p-gp inhibitor 29  (Chemgen Corporation)
90
Chemgen Corporation docking routine-identified variants of p-gp inhibitor 29
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
Docking Routine Identified Variants Of P Gp Inhibitor 29, supplied by Chemgen Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pmc07031812-157-4-0?v=Chemgen+Corporation
Average 90 stars, based on 1 article reviews
docking routine-identified variants of p-gp inhibitor 29 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
3-[(4-chlorophenyl) amino]-5-methyl-2-cyclohexenone  (Biopharm GmbH)
90
Biopharm GmbH 3-[(4-chlorophenyl) amino]-5-methyl-2-cyclohexenone
Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor <t>zosuquidar</t> (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)
3 [(4 Chlorophenyl) Amino] 5 Methyl 2 Cyclohexenone, supplied by Biopharm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p-gp+inhibitors/pm14689468-30-10-23?v=Biopharm+GmbH
Average 90 stars, based on 1 article reviews
3-[(4-chlorophenyl) amino]-5-methyl-2-cyclohexenone - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor zosuquidar (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)

Journal: EJNMMI Research

Article Title: Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18 F-fluorination of boroxines, in vitro and initial in vivo evaluation

doi: 10.1186/s13550-024-01141-2

Figure Lengend Snippet: Basolateral-to-apical transport of the P-gp substrate digoxin in P-gp expressing Caco-2 monolayers in the absence and presence of the P-gp inhibitor zosuquidar (ZSQ) ( A ) compared to basolateral-to-apical transport of 1c , 1f , 1b and 1d in the presence and absence of ZSQ ( B ). Amounts being present after 4 h in the apical compartment are shown in % of the amount administered to the basal side. Digoxin and all test compounds were each used in a concentration of 5 µM (ns: p ≥ 0.05, *p < 0.05, ***p < 0.001, n = 8)

Article Snippet: In brief, transport from the basolateral to apical compartment was determined after 4 h in the absence or presence of the P-gp inhibitor zosuquidar (Biomol GmbH, Hamburg, Germany).

Techniques: Expressing, Concentration Assay